In vitro and ex vivo platforms
Leverage our cutting-edge technologies for mode-of-action studies and compound profiling:
- High-content imaging and functional readouts (e.g., neuronal activity and viability)
- Biomarker discovery using genomics, proteomics, and spatial profiling
- Custom assay development for neuroinflammation and synaptic activity.
Translational biomarker services
We bridge preclinical findings to clinical applications through:
- Biomarker indication profiling from CNS and pain models
- Validation in human tissues and biobank-based analysis
- Integration of pharmacokinetic/pharmacodynamic (PK/PD) relationships to optimise dosing and efficacy.
Key capabilities
Our neurology-focused capabilities include:
- Microelectrode array (MEA) with the Axion Maestro Pro for functional analyses of excitable cells
- Advanced imaging techniques: in vivo bioluminescence, fluorescence and µCT
- Assay-ready organoid systems for Alzheimer’s and Parkinson’s disease studies
- Quantitative PCR and proteomics for myelin protein assessment.
